Jacobson TA - Search Results

1

Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk.

Robinson JG, Wang S, Smith BJ, Jacobson TA. Robinson JG, et al. Among authors: jacobson ta. J Am Coll Cardiol. 2009 Jan 27;53(4):316-22. doi: 10.1016/j.jacc.2008.10.024. J Am Coll Cardiol. 2009. PMID: 19161879 Free article.

2

Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.

Verma S, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Dhingra NK, Ketchum SB, Juliano RA, Jiao L, Doyle RT Jr, Granowitz C, Gibson CM, Pinto D, Giugliano RP, Budoff MJ, Mason RP, Tardif JC, Ballantyne CM; REDUCE-IT Investigators. Verma S, et al. Among authors: jacobson ta. Circulation. 2021 Dec 7;144(23):1845-1855. doi: 10.1161/CIRCULATIONAHA.121.056290. Epub 2021 Oct 28. Circulation. 2021. PMID: 34710343 Free article. Clinical Trial.

3

Management of persons with high risk of coronary heart disease but low serum low-density lipoprotein cholesterol.

Case CC, Jacobson TA, Roberts S, Buckley A, Murtaugh KM, Sung JC, Gause D, Varas C, Ballantyne CM. Case CC, et al. Among authors: jacobson ta. Am J Cardiol. 2003 May 1;91(9):1134-6. doi: 10.1016/s0002-9149(03)00167-x. Am J Cardiol. 2003. PMID: 12714165 No abstract available.

4

30-year trends in serum lipids among United States adults: results from the National Health and Nutrition Examination Surveys II, III, and 1999-2006.

Cohen JD, Cziraky MJ, Cai Q, Wallace A, Wasser T, Crouse JR, Jacobson TA. Cohen JD, et al. Among authors: jacobson ta. Am J Cardiol. 2010 Oct 1;106(7):969-75. doi: 10.1016/j.amjcard.2010.05.030. Epub 2010 Aug 11. Am J Cardiol. 2010. PMID: 20854959

5

Risk for myopathy with statin therapy in high-risk patients.

Ballantyne CM, Corsini A, Davidson MH, Holdaas H, Jacobson TA, Leitersdorf E, März W, Reckless JP, Stein EA. Ballantyne CM, et al. Among authors: jacobson ta. Arch Intern Med. 2003 Mar 10;163(5):553-64. doi: 10.1001/archinte.163.5.553. Arch Intern Med. 2003. PMID: 12622602 Review.

6

Statin safety: an assessment using an administrative claims database.

Cziraky MJ, Willey VJ, McKenney JM, Kamat SA, Fisher MD, Guyton JR, Jacobson TA, Davidson MH. Cziraky MJ, et al. Among authors: jacobson ta. Am J Cardiol. 2006 Apr 17;97(8A):61C-68C. doi: 10.1016/j.amjcard.2005.12.011. Epub 2006 Jan 30. Am J Cardiol. 2006. PMID: 16581331

7

Safety considerations with fibrate therapy.

Davidson MH, Armani A, McKenney JM, Jacobson TA. Davidson MH, et al. Among authors: jacobson ta. Am J Cardiol. 2007 Mar 19;99(6A):3C-18C. doi: 10.1016/j.amjcard.2006.11.016. Epub 2006 Dec 8. Am J Cardiol. 2007. PMID: 17368275 Review.

8

Fluvastatin: clinical and safety profile.

Corsini A, Jacobson TA, Ballantyne CM. Corsini A, et al. Among authors: jacobson ta. Drugs. 2004;64(12):1305-23. doi: 10.2165/00003495-200464120-00004. Drugs. 2004. PMID: 15200346 Review.

9

Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.

McKenney JM, Davidson MH, Jacobson TA, Guyton JR; National Lipid Association Statin Safety Assessment Task Force. McKenney JM, et al. Among authors: jacobson ta. Am J Cardiol. 2006 Apr 17;97(8A):89C-94C. doi: 10.1016/j.amjcard.2006.02.030. Epub 2006 Feb 28. Am J Cardiol. 2006. PMID: 16581336

10

Safety considerations with gastrointestinally active lipid-lowering drugs.

Jacobson TA, Armani A, McKenney JM, Guyton JR. Jacobson TA, et al. Am J Cardiol. 2007 Mar 19;99(6A):47C-55C. doi: 10.1016/j.amjcard.2006.11.022. Epub 2006 Nov 29. Am J Cardiol. 2007. PMID: 17368279

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

208 results

Search Page